Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 1278
Selected: 0
NCT IDTitle
NCT01568346Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision Lumpectomy
NCT03447886Understanding Barriers to Initiation and Adherence to Endocrine Therapy in Young Breast Cancer Survivors of Diverse Backgrounds
NCT00806715Iron Overload in Stem Cell Transplant Recipients
NCT03777410Mass Accumulation Rate (MAR) as a Predictive Biomarker in Multiple Myeloma
NCT00136396Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease
NCT00117156Fludarabine and Rituximab for the Treatment of Marginal Zone Non-Hodgkin's Lymphoma
NCT00119730Chemotherapy Followed by Zevalin for Relapsed Mantle Cell Lymphoma
NCT06844383A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate
NCT02282722Improving Informed Consent for Palliative Chemotherapy
NCT06313437Revumenib in Combination With 7+3 + Midostaurin in AML
NCT06716580EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations
NCT03065062Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors
NCT03328091Genetic Counseling Processes and Outcomes Among Males With Prostate Cancer (ProGen)
NCT06015659ZN-c3 + Gemcitabine in Pancreatic Cancer
NCT04115059Dasatinib In Waldenström Macroglobulinemia
NCT00487513Procurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use in Future Clinical Trials
NCT00642759Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer
NCT03289039Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer
NCT04895436Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
NCT03936465Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer
NCT02269592Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
NCT01027910PCI-24781 in Combination With Doxorubicin to Treat Sarcoma
NCT05234983Adapting and Evaluating a Brief Advice Tobacco Intervention in High-Reach, Low-Resource Settings in India
NCT04448886Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC
NCT01485744LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer
NCT04938232Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL
NCT05918263Exercise for Tumor Suppressive Impact in Black Men With Prostate Cancer on Active Surveillance: The REMOVE Trial
NCT02285439Study of MEK162 for Children With Low-Grade Gliomas
NCT06321484Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer
NCT03289676Storytelling Narrative Communication Intervention for Smoking Cessation in Women Living With HIV
NCT02355340Bone Mineral Density Status in Pediatric and Adolescent Survivors of Childhood Cancer With History of Bone Fracture
NCT01002248Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients
NCT03170648Ear Acupuncture During Chemotherapy Infusion for Breast Cancer, a Feasibility Study
NCT03789110NIMBUS: Nivolumab Plus Ipilimumab in Metastatic Hypermutated HER2-negative Breast Cancer
NCT01978899Healthy Living After Cancer: Weight Management Pilot Study
NCT00165087Treatment of Childhood Acute Lymphoblastic Leukemia
NCT06582914Lynch Syndrome Integrative Epidemiology and Genetics
NCT02981940A Study of Abemaciclib in Recurrent Glioblastoma
NCT00801320Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer
NCT05519982Sleep Treatment Education Program-1 (STEP-1)
NCT06945120ACT Lung Health Intervention: Phase Two
NCT02871791Palbociclib With Everolimus + Exemestane In BC
NCT03520790Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer
NCT04040725Rogaratinib for BCG Refractory High Risk Non-Muscle Invasive Bladder Cancer With FGFR1/2 Overexpression
NCT00813293Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer
NCT00953576Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer
NCT00657267Dose-Intense Temozolomide in Recurrent Glioblastoma
NCT00251407Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor Malignancies
NCT04653246Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in NDMM
NCT00694603Cetuximab as Therapy for Recurrent Non-Small Cell Lung Cancer Patients Who Have Received Prior Therapy